BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT, Rao VK. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 2010;116:e35-40. [PMID: 20538792 DOI: 10.1182/blood-2010-04-280347] [Cited by in Crossref: 300] [Cited by in F6Publishing: 230] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Leechawengwongs E, Shearer WT. Lymphoma complicating primary immunodeficiency syndromes: . Current Opinion in Hematology 2012;19:305-12. [DOI: 10.1097/moh.0b013e328353fa13] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
2 Kishore R, Gupta A, Gupta AK, Kabra SK. Novel mutation in the CD27 gene in a patient presenting with hypogammaglobulinemia, bronchiectasis and EBV-driven lymphoproliferative disease. BMJ Case Rep 2020;13:e233482. [PMID: 32041749 DOI: 10.1136/bcr-2019-233482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Nabhani S, Schipp C, Miskin H, Levin C, Postovsky S, Dujovny T, Koren A, Harlev D, Bis AM, Auer F, Keller B, Warnatz K, Gombert M, Ginzel S, Borkhardt A, Stepensky P, Fischer U. STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds. Clin Immunol 2017;181:32-42. [PMID: 28579554 DOI: 10.1016/j.clim.2017.05.021] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
4 LeBlanc RE, Lansigan F. Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis. J Cutan Pathol 2021;48:572-7. [PMID: 32894575 DOI: 10.1111/cup.13863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ramaswamy M, Siegel RM. Autoimmunity: twenty years in the Fas lane. J Immunol 2012;189:5097-100. [PMID: 23169861 DOI: 10.4049/jimmunol.1202833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Maggiore R, Grossi A, Fioredda F, Palmisani E, Terranova P, Cappelli E, Lanza T, Pierri F, Guardo D, Calvillo M, Micalizzi C, Beccaria A, Coccia MC, Arrigo S, Dufour C, Ceccherini I, Miano M. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency. J Pediatr Hematol Oncol 2020;42:e768-71. [PMID: 31876783 DOI: 10.1097/MPH.0000000000001708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Maródi L. Inborn errors of T cell immunity underlying autoimmune diseases. Expert Rev Clin Immunol 2017;13:97-9. [PMID: 27801603 DOI: 10.1080/1744666X.2017.1256204] [Reference Citation Analysis]
8 Mantadakis E, Farmaki E. Natural History, Pathogenesis, and Treatment of Evans Syndrome in Children. J Pediatr Hematol Oncol 2017;39:413-9. [PMID: 28654461 DOI: 10.1097/MPH.0000000000000897] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
9 Neven B, Bruneau J, Stolzenberg MC, Meyts I, Magerus-Chatinet A, Moens L, Lanzarotti N, Weller S, Amiranoff D, Florkin B, Bader-Meunier B, Leverger G, Ferster A, Chantrain C, Blanche S, Picard C, Molina TJ, Brousse N, Durandy A, Rizzi M, Bossuyt X, Fischer A, Rieux-Laucat F. Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients. Blood 2014;124:1597-609. [PMID: 24970930 DOI: 10.1182/blood-2014-02-553834] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
10 Rao VK. Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome. Front Pediatr 2015;3:65. [PMID: 26258116 DOI: 10.3389/fped.2015.00065] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
11 Lo B, Ramaswamy M, Davis J, Price S, Rao VK, Siegel RM, Lenardo MJ. A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis. J Clin Immunol 2013;33:479-88. [PMID: 23054345 DOI: 10.1007/s10875-012-9811-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Torgerson TR. Immunodeficiency diseases with rheumatic manifestations. Pediatr Clin North Am 2012;59:493-507. [PMID: 22560581 DOI: 10.1016/j.pcl.2012.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
13 Lo B, Ramaswamy M. Determination of Apoptosis Sensitivity in Specific T Cell Subsets from Human Peripheral Blood by Utilizing a Multiparameter Fluorescence-Activated Cell Sorting-Based Technique. In: Snow AL, Lenardo MJ, editors. Immune Homeostasis. Totowa: Humana Press; 2013. pp. 33-41. [DOI: 10.1007/978-1-62703-290-2_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Palmisani E, Miano M, Micalizzi C, Calvillo M, Pierri F, Terranova P, Lanza T, Lanciotti M, Riccardi F, Todiere A, Zanardi S, Caviglia I, Dufour C, Fioredda F. Clinical features and therapeutic challenges of cytopenias belonging to alps and alps-related (ARS) phenotype. Br J Haematol 2019;184:861-4. [PMID: 29527658 DOI: 10.1111/bjh.15178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
15 Alvarez-Diaz S, Dillon CP, Lalaoui N, Tanzer MC, Rodriguez DA, Lin A, Lebois M, Hakem R, Josefsson EC, O'Reilly LA, Silke J, Alexander WS, Green DR, Strasser A. The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis. Immunity 2016;45:513-26. [PMID: 27523270 DOI: 10.1016/j.immuni.2016.07.016] [Cited by in Crossref: 119] [Cited by in F6Publishing: 117] [Article Influence: 19.8] [Reference Citation Analysis]
16 Locke BA, Dasu T, Verbsky JW. Laboratory diagnosis of primary immunodeficiencies. Clin Rev Allergy Immunol 2014;46:154-68. [PMID: 24569953 DOI: 10.1007/s12016-014-8412-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
17 Judge A, O'Shaughnessy S, McCaul C. Anaesthetic management of an emergency caesarean section in a complex immunologically compromised patient with pre-eclampsia and multifactorial thrombocytopaenia. Anaesth Rep 2020;8:131-4. [PMID: 33210090 DOI: 10.1002/anr3.12077] [Reference Citation Analysis]
18 Aberdein D, Munday JS, Fairley RA, Vernau W, Thompson KG. A Novel and Likely Inherited Lymphoproliferative Disease in British Shorthair Kittens. Vet Pathol 2015;52:1176-82. [DOI: 10.1177/0300985815586224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Viallard JF, Parrens M, Rieux-Laucat F. Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition? Case Reports Immunol 2019;2019:2543038. [PMID: 31956452 DOI: 10.1155/2019/2543038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rivalta B, Zama D, Pancaldi G, Facchini E, Cantarini ME, Miniaci A, Prete A, Pession A. Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease. Front Pediatr 2019;7:304. [PMID: 31396497 DOI: 10.3389/fped.2019.00304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mattheij MA, Schatorjé EJ, Gemen EF, van de Corput L, Nooijen PT, van der Burg M, de Vries E. A girl with autoimmune cytopenias, nonmalignant lymphadenopathy, and recurrent infections. Case Reports Immunol 2012;2012:196417. [PMID: 25379303 DOI: 10.1155/2012/196417] [Reference Citation Analysis]
22 Madkaikar M, Mhatre S, Gupta M, Ghosh K. Advances in autoimmune lymphoproliferative syndromes: ALPS. European Journal of Haematology 2011;87:1-9. [DOI: 10.1111/j.1600-0609.2011.01617.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
23 Oliveira JB. Marginal zone B-cell dysfunction in ALPS. Blood 2014;124:1542-3. [PMID: 25190747 DOI: 10.1182/blood-2014-07-585935] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Rensing-Ehl A, Warnatz K, Fuchs S, Schlesier M, Salzer U, Draeger R, Bondzio I, Joos Y, Janda A, Gomes M, Abinun M, Hambleton S, Cant A, Shackley F, Flood T, Waruiru C, Beutel K, Siepermann K, Dueckers G, Niehues T, Wiesel T, Schuster V, Seidel MG, Minkov M, Sirkiä K, Kopp MV, Korhonen M, Schwarz K, Ehl S, Speckmann C. Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency. Clin Immunol 2010;137:357-65. [PMID: 20832369 DOI: 10.1016/j.clim.2010.08.008] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
25 Wang W, Li H, Zhang L, Jiang W, Shen L, Fan G. Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry. Int J Lab Hematol 2021. [PMID: 33870648 DOI: 10.1111/ijlh.13541] [Reference Citation Analysis]
26 Bass GF, Tuscano ET, Tuscano JM. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmunity Reviews 2014;13:560-4. [DOI: 10.1016/j.autrev.2013.11.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 48] [Article Influence: 8.4] [Reference Citation Analysis]
27 Nabhani S, Ginzel S, Miskin H, Revel-Vilk S, Harlev D, Fleckenstein B, Hönscheid A, Oommen PT, Kuhlen M, Thiele R, Laws HJ, Borkhardt A, Stepensky P, Fischer U. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease. Haematologica 2015;100:1189-98. [PMID: 26113417 DOI: 10.3324/haematol.2014.114967] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
28 Bajwa R, Savelli S, Gross T. Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome. Pediatr Blood Cancer 2011;57:336-7. [PMID: 21495163 DOI: 10.1002/pbc.23144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
29 Ucar D, Kim JS, Bishop RJ, Nussenblatt RB, Rao VK, Sen HN. Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS). Ocul Immunol Inflamm 2017;25:703-9. [PMID: 27229379 DOI: 10.1080/09273948.2016.1175637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Kohrogi K, Migita M, Anan T, Sugahara T, Yoshimoto K, Kanegane H, Nakamura K. Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture. J Clin Immunol 2020;40:780-2. [PMID: 32583203 DOI: 10.1007/s10875-020-00809-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Sumnik Z, Sediva A, Slatter M, Arkwright PD, Cant A, Lorenz HM, Giese T, Lougaris V, Plebani A, Price C, Sullivan KE, Moutschen M, Litzman J, Freiberger T, van de Veerdonk FL, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Speckmann C, Ehl S, Leichtner A, Blumberg R, Franke A, Snapper S, Zeissig S, Cunningham-Rundles C, Giulino-Roth L, Elemento O, Dückers G, Niehues T, Fronkova E, Kanderová V, Platt CD, Chou J, Chatila TA, Geha R, McDermott E, Bunn S, Kurzai M, Schulz A, Alsina L, Casals F, Deyà-Martinez A, Hambleton S, Kanegane H, Taskén K, Neth O, Grimbacher B. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol 2018;142:1932-46. [PMID: 29729943 DOI: 10.1016/j.jaci.2018.02.055] [Cited by in Crossref: 167] [Cited by in F6Publishing: 151] [Article Influence: 41.8] [Reference Citation Analysis]
32 Levy-Mendelovich S, Lev A, Rechavi E, Barel O, Golan H, Bielorai B, Neumann Y, Simon AJ, Somech R. T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing. Clin Exp Immunol 2017;189:310-7. [PMID: 28500641 DOI: 10.1111/cei.12986] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
33 Molnár E, Radwan N, Kovács G, Andrikovics H, Henriquez F, Zarafov A, Hayman M, Linzner D, Thrasher AJ, Buckland M, Burns SO, Gilmour KC. Key diagnostic markers for autoimmune lymphoproliferative syndrome with molecular genetic diagnosis. Blood 2020;136:1933-45. [DOI: 10.1182/blood.2020005486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
34 Lafont E. Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer. Cancers (Basel) 2020;12:E1113. [PMID: 32365592 DOI: 10.3390/cancers12051113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
35 Gu H, Ma J, Chen Z, Wang J, Zhang R, Wu R. Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report. Gene 2018;672:45-9. [PMID: 29864493 DOI: 10.1016/j.gene.2018.05.097] [Reference Citation Analysis]
36 Barrett D, Brown VI, Grupp SA, Teachey DT. Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies. Paediatr Drugs 2012;14:299-316. [PMID: 22845486 DOI: 10.2165/11594740-000000000-00000] [Cited by in Crossref: 16] [Cited by in F6Publishing: 44] [Article Influence: 1.8] [Reference Citation Analysis]
37 Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chêne G, Perel Y; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE). New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 2011;96:655-63. [PMID: 21228033 DOI: 10.3324/haematol.2010.036053] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 10.2] [Reference Citation Analysis]
38 Hafezi N, Zaki-Dizaji M, Nirouei M, Asadi G, Sharifinejad N, Jamee M, Erfan Rasouli S, Hamedifar H, Sabzevari A, Chavoshzadeh Z, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review. Pediatr Allergy Immunol 2021. [PMID: 33963613 DOI: 10.1111/pai.13535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Al Ghaithi I, Wright NA, Breakey VR, Cox K, Warias A, Wong T, O'connell C, Price V. Combined Autoimmune Cytopenias Presenting in Childhood: Combined Autoimmune Cytopenias in Childhood. Pediatr Blood Cancer 2016;63:292-8. [DOI: 10.1002/pbc.25769] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
40 Patti S, Perrone G, De Pratti V, Quinti I, Milito C, Brunelli R. Autoimmune lymphoproliferative syndrome in pregnancy: A case of favorable mother-fetal outcome in a well-controlled disease: ALPS and pregnancy outcome. J Obstet Gynaecol Res 2015;41:460-3. [DOI: 10.1111/jog.12556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 van de Ven AA, Warnatz K. The autoimmune conundrum in common variable immunodeficiency disorders. Curr Opin Allergy Clin Immunol 2015;15:514-24. [PMID: 26485099 DOI: 10.1097/ACI.0000000000000218] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
42 Grimbacher B, Warnatz K, Yong PF, Korganow A, Peter H. The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects. Journal of Allergy and Clinical Immunology 2016;137:3-17. [DOI: 10.1016/j.jaci.2015.11.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 11.2] [Reference Citation Analysis]
43 Lehman HK. Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders. Curr Allergy Asthma Rep 2015;15:53. [PMID: 26233425 DOI: 10.1007/s11882-015-0553-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
44 Teachey DT. Targeting cytokines in ALPS: it's FAShionable. Blood 2014;123:1116-8. [PMID: 24558187 DOI: 10.1182/blood-2014-01-546713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Chadburn A. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8). Seminars in Diagnostic Pathology 2013;30:113-29. [DOI: 10.1053/j.semdp.2012.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
46 Todorova TT, Ermenlieva N, Tsankova G. Vitamin B12: Could It Be a Promising Immunotherapy? In: Metodiev K, editor. Immunotherapy - Myths, Reality, Ideas, Future. InTech; 2017. [DOI: 10.5772/65729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
47 Tarbox JA, Keppel MP, Topcagic N, Mackin C, Ben Abdallah M, Baszis KW, White AJ, French AR, Cooper MA. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol 2014;34:594-9. [PMID: 24760111 DOI: 10.1007/s10875-014-0038-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
48 Tran TAN, Grow WB, Chang C. Superficial and Deep Cutaneous Involvement by RAS-Associated Autoimmunne Leukoproliferative Disease (RALD Cutis): A Histologic Mimicker of Histiocytoid Sweet Syndrome. The American Journal of Dermatopathology 2019;41:606-10. [DOI: 10.1097/dad.0000000000001332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
49 Mu K, Zhang J, Gu Y, Li H, Wang H. Autoimmune Lymphoproliferative Syndrome with Cryptococcus Infection. J Clin Immunol 2019;39:747-9. [PMID: 31402412 DOI: 10.1007/s10875-019-00676-7] [Reference Citation Analysis]
50 Kwon WK, Choi S, Kim HJ, Huh HJ, Kang JM, Kim YJ, Yoo KH, Ahn K, Cho HK, Peck KR, Jang JH, Ki CS, Kang ES. Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience. Allergy Asthma Immunol Res 2020;12:292-305. [PMID: 32009323 DOI: 10.4168/aair.2020.12.2.292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Shannon K, Li Q. Oncogenic Ras scales the ALPS. Blood 2011;117:2747-8. [DOI: 10.1182/blood-2010-12-320721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
52 Hansford JR, Pal M, Poplawski N, Haan E, Boog B, Ferrante A, Davis J, Niemela JE, Rao VK, Suppiah R. In utero and early postnatal presentation of autoimmune lymphoproliferative syndrome in a family with a novel FAS mutation. Haematologica 2013;98:e38-9. [PMID: 22983578 DOI: 10.3324/haematol.2012.070524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Aricò M, Boggio E, Cetica V, Melensi M, Orilieri E, Clemente N, Cappellano G, Buttini S, Soluri MF, Comi C, Dufour C, Pende D, Dianzani I, Ellis SR, Pagliano S, Marcenaro S, Ramenghi U, Chiocchetti A, Dianzani U. Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome. PLoS One 2013;8:e68045. [PMID: 23840885 DOI: 10.1371/journal.pone.0068045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
54 Agrebi N, Sfaihi Ben-mansour L, Medhaffar M, Hadiji S, Fedhila F, Ben-ali M, Mekki N, Hachicha M, Barsaoui S, Barbouche M, Ben-mustapha I. Autoimmune lymphoproliferative syndrome caused by homozygous FAS mutations with normal or residual protein expression. Journal of Allergy and Clinical Immunology 2017;140:298-301.e3. [DOI: 10.1016/j.jaci.2016.11.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
55 Goode E, Smith JA, Gilpatrick M, Matney C, Borch-Christensen B, Henry MM. Autoimmune lymphoproliferative syndrome with Langerhans cell histiocytosis diagnosis. Pediatr Blood Cancer 2021;:e29301. [PMID: 34398530 DOI: 10.1002/pbc.29301] [Reference Citation Analysis]
56 Kinjyo I, Gordon SM, Intlekofer AM, Dowdell K, Mooney EC, Caricchio R, Grupp SA, Teachey DT, Rao VK, Lindsten T, Reiner SL. Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin. J Immunol 2010;185:7151-5. [PMID: 21076068 DOI: 10.4049/jimmunol.1003193] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
57 Oliveira JB. The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr 2013;25:722-9. [PMID: 24240292 DOI: 10.1097/MOP.0000000000000032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
58 Renzi S, Langenberg-Ververgaert KPS, Waespe N, Ali S, Bartram J, Michaeli O, Upton J, Cada M. Primary immunodeficiencies and their associated risk of malignancies in children: an overview. Eur J Pediatr 2020;179:689-97. [PMID: 32162064 DOI: 10.1007/s00431-020-03619-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Lambotte O, Neven B, Galicier L, Magerus-Chatinet A, Schleinitz N, Hermine O, Meyts I, Picard C, Godeau B, Fischer A, Rieux-Laucat F. Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults. Haematologica 2013;98:389-92. [PMID: 22983577 DOI: 10.3324/haematol.2012.067488] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
60 Cabral-Marques O, Schimke LF, de Oliveira EB Jr, El Khawanky N, Ramos RN, Al-Ramadi BK, Segundo GRS, Ochs HD, Condino-Neto A. Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation. Front Immunol 2019;10:2742. [PMID: 31849949 DOI: 10.3389/fimmu.2019.02742] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
61 Dell'Orso G, Grossi A, Penco F, Caorsi R, Palmisani E, Terranova P, Schena F, Lupia M, Ricci E, Montalto S, Pierri F, Ceccherini I, Fioredda F, Dufour C, Gattorno M, Miano M. Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure. Front Immunol 2021;12:754029. [PMID: 34721429 DOI: 10.3389/fimmu.2021.754029] [Reference Citation Analysis]
62 Mendonça LO, Matucci-Cerinic C, Terranova P, Casabona F, Bovis F, Caorsi R, Fioredda F, Palmisani E, Grossi A, Guardo D, Bustaffa M, Volpi S, Ceccherini I, Ravelli A, Dufour C, Miano M, Gattorno M. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders. Rheumatology (Oxford) 2021:keab361. [PMID: 33909886 DOI: 10.1093/rheumatology/keab361] [Reference Citation Analysis]
63 Ogishi M, Yang R, Gruber C, Zhang P, Pelham SJ, Spaan AN, Rosain J, Chbihi M, Han JE, Rao VK, Kainulainen L, Bustamante J, Boisson B, Bogunovic D, Boisson-Dupuis S, Casanova JL. Multibatch Cytometry Data Integration for Optimal Immunophenotyping. J Immunol 2021;206:206-13. [PMID: 33229441 DOI: 10.4049/jimmunol.2000854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Takagi M, Ogata S, Ueno H, Yoshida K, Yeh T, Hoshino A, Piao J, Yamashita M, Nanya M, Okano T, Kajiwara M, Kanegane H, Muramatsu H, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Bando Y, Kato M, Hayashi Y, Miyano S, Imai K, Ogawa S, Kojima S, Morio T. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol 2017;139:1914-22. [PMID: 27845235 DOI: 10.1016/j.jaci.2016.09.038] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 10.5] [Reference Citation Analysis]
65 Hsu AP, Dowdell KC, Davis J, Niemela JE, Anderson SM, Shaw PA, Rao VK, Puck JM. Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance. Genet Med 2012;14:81-9. [PMID: 22237435 DOI: 10.1038/gim.0b013e3182310b7d] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
66 Martínez-feito A, Melero J, Mora-díaz S, Rodríguez-vigil C, Elduayen R, González-granado LI, Pérez-méndez D, Sánchez-zapardiel E, Ruiz-garcía R, Menchén M, Díaz-madroñero J, Paz-artal E, del Orbe-barreto R, Riñón M, Allende LM. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation. Immunobiology 2016;221:40-7. [DOI: 10.1016/j.imbio.2015.08.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
67 Rananaware SR, Pathak S, Chakraborty S, Bisen RY, Chattopadhyay A, Nandi D. Autoimmune-prone lpr mice exhibit a prolonged but lethal infection with an attenuated Salmonella Typhimurium strain. Microb Pathog 2021;150:104684. [PMID: 33301858 DOI: 10.1016/j.micpath.2020.104684] [Reference Citation Analysis]
68 Aluri J, Cooper MA. Genetic Mosaicism as a Cause of Inborn Errors of Immunity. J Clin Immunol 2021;41:718-28. [PMID: 33864184 DOI: 10.1007/s10875-021-01037-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Lambert MP. Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS). Expert Rev Clin Immunol 2021;17:1163-73. [PMID: 34503378 DOI: 10.1080/1744666X.2021.1978842] [Reference Citation Analysis]
70 Lobito AA, Gabriel TL, Medema JP, Kimberley FC. Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease. Trends Mol Med 2011;17:494-505. [PMID: 21724465 DOI: 10.1016/j.molmed.2011.05.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
71 Lube GE, Ferriani MP, Campos LM, Terreri MT, Bonfá E, Magalhães CS, Aikawa NE, Piotto DP, Peracchi OA, Dos Santos MC, Appenzeller S, Ferriani VP, Pereira RM, Silva CA. Evans Syndrome at Childhood-Onset Systemic Lupus Erythematosus Diagnosis: A Large Multicenter Study. Pediatr Blood Cancer 2016;63:1238-43. [PMID: 27018636 DOI: 10.1002/pbc.25976] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
72 Salem AE, Zaki YH, El-Hussieny G, ElNoueam KI, Shaaban AM, Koppula BR, Bustoros M, Salama M, Elsayes KM, Morton K, Covington MF. An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features. Cancers (Basel) 2021;13:5853. [PMID: 34831006 DOI: 10.3390/cancers13225853] [Reference Citation Analysis]
73 Rotz SJ, Ware RE, Kumar A. Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults. Pediatr Blood Cancer 2018;65:e27260. [PMID: 29856527 DOI: 10.1002/pbc.27260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
74 Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarström L, Nonoyama S, Quinti I, Routes JM, Tang ML, Warnatz K. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract 2016;4:38-59. [PMID: 26563668 DOI: 10.1016/j.jaip.2015.07.025] [Cited by in Crossref: 366] [Cited by in F6Publishing: 300] [Article Influence: 52.3] [Reference Citation Analysis]
75 Gu H, Chen Z, Ma J, Wang J, Zhang R, Wu R, Wang T. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD. Int J Immunopathol Pharmacol 2021;35:20587384211025934. [PMID: 34187243 DOI: 10.1177/20587384211025934] [Reference Citation Analysis]
76 Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000Res 2017;6:1928. [PMID: 29123652 DOI: 10.12688/f1000research.11545.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
77 Consonni F, Favre C, Gambineri E. IL-2 Signaling Axis Defects: How Many Faces? Front Pediatr 2021;9:669298. [PMID: 34277517 DOI: 10.3389/fped.2021.669298] [Reference Citation Analysis]
78 Lee-Brennan C, O'Reilly M, Smith O, Quinn J, Murphy P, Keogan M. A diagnostic dilemma in AL(L)PS. Ann Hematol 2014;93:515-6. [PMID: 23783422 DOI: 10.1007/s00277-013-1823-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Minemura H, Tanino Y, Ikeda K. Possible Association of Multicentric Castleman's Disease with Autoimmune Lymphoproliferative Syndrome. Biores Open Access 2018;7:47-51. [PMID: 29682404 DOI: 10.1089/biores.2017.0025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
80 Miano M. How I manage Evans Syndrome and AIHA cases in children. Br J Haematol 2016;172:524-34. [DOI: 10.1111/bjh.13866] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
81 de Bielke MGS, Perez L, Yancoski J, Oliveira JB, Danielian S. FAS Haploinsufficiency Caused by Extracellular Missense Mutations Underlying Autoimmune Lymphoproliferative Syndrome. J Clin Immunol 2015;35:769-76. [DOI: 10.1007/s10875-015-0210-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
82 Comi C, Fleetwood T, Dianzani U. The role of T cell apoptosis in nervous system autoimmunity. Autoimmun Rev 2012;12:150-6. [PMID: 22504460 DOI: 10.1016/j.autrev.2011.08.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
83 Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y. Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. Am J Clin Pathol 2017;147:204-16. [PMID: 28395106 DOI: 10.1093/ajcp/aqw215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
84 Barzaghi F, Minniti F, Mauro M, Bortoli M, Balter R, Bonetti E, Zaccaron A, Vitale V, Omrani M, Zoccolillo M, Brigida I, Cicalese MP, Degano M, Hershfield MS, Aiuti A, Bondarenko AV, Chinello M, Cesaro S. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2018;9:2767. [PMID: 30692987 DOI: 10.3389/fimmu.2018.02767] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
85 Gámez-Díaz L, Grimbacher B. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes. Biomed J 2021:S2319-4170(21)00038-X. [PMID: 34384744 DOI: 10.1016/j.bj.2021.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Meeths M, Chiang SC, Löfstedt A, Müller M, Tesi B, Henter J, Bryceson YT. Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity. Experimental Cell Research 2014;325:10-7. [DOI: 10.1016/j.yexcr.2014.03.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
87 Shah S, Wu E, Rao VK, Tarrant TK. Autoimmune lymphoproliferative syndrome: an update and review of the literature. Curr Allergy Asthma Rep 2014;14:462. [PMID: 25086580 DOI: 10.1007/s11882-014-0462-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
88 Miano M, Cappelli E, Pezzulla A, Venè R, Grossi A, Terranova P, Palmisani E, Maggiore R, Guardo D, Lanza T, Calvillo M, Micalizzi C, Pierri F, Vernarecci C, Beccaria A, Corsolini F, Lanciotti M, Russo G, Ceccherini I, Dufour C, Fioredda F. FAS‐mediated apoptosis impairment in patients with ALPS/ALPS‐like phenotype carrying variants on CASP10 gene. Br J Haematol 2019;187:502-8. [DOI: 10.1111/bjh.16098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
89 Kühne T. Diagnosis and management of immune thrombocytopenia in childhood. Hamostaseologie 2017;37:36-44. [PMID: 27699328 DOI: 10.5482/HAMO-16-06-0017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
90 Boggio E, Melensi M, Bocca S, Chiocchetti A, Comi C, Clemente N, Orilieri E, Soluri MF, D'Alfonso S, Mechelli R, Gentile G, Poggi A, Salvetti M, Ramenghi U, Dianzani U. The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function. Hum Immunol 2012;73:585-92. [PMID: 22425739 DOI: 10.1016/j.humimm.2012.02.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Ortiz MV, Skoda-smith S, Rauen KA, Allan RW, Slayton WB. Juvenile Myelomonocytic Leukemia in a 16-Year-Old With Noonan Syndrome: Case Report. Journal of Pediatric Hematology/Oncology 2012;34:569-72. [DOI: 10.1097/mph.0b013e31824e192a] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
92 Richardson AM, Moyer AM, Hasadsri L, Abraham RS. Diagnostic Tools for Inborn Errors of Human Immunity (Primary Immunodeficiencies and Immune Dysregulatory Diseases). Curr Allergy Asthma Rep 2018;18:19. [PMID: 29470720 DOI: 10.1007/s11882-018-0770-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
93 Rudman Spergel A, Walkovich K, Price S, Niemela JE, Wright D, Fleisher TA, Rao VK. Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis. Pediatrics 2013;132:e1440-4. [PMID: 24101757 DOI: 10.1542/peds.2012-2748] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
94 Niemela JE, Lu L, Fleisher TA, Davis J, Caminha I, Natter M, Beer LA, Dowdell KC, Pittaluga S, Raffeld M, Rao VK, Oliveira JB. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood 2011;117:2883-6. [PMID: 21079152 DOI: 10.1182/blood-2010-07-295501] [Cited by in Crossref: 107] [Cited by in F6Publishing: 81] [Article Influence: 8.9] [Reference Citation Analysis]
95 Kaya Z, Işık M, Oruklu N, Kirkiz S, Bağrıaçık EÜ, Allende LM, Díaz-Madroñero MJ, Ruiz-García R, Pınarlı FG, Göçün Uyar P, Koçak Ü. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma. Turk J Haematol 2021;38:145-50. [PMID: 33375216 DOI: 10.4274/tjh.galenos.2020.2020.0618] [Reference Citation Analysis]
96 Meena KR, Bisht S, Tamaria KC. Autoimmune Lymphoproliferative Syndrome with Red Cell Aplasia. Indian J Pediatr 2015;82:1172-4. [DOI: 10.1007/s12098-015-1779-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Jeffreys SM, Levy RA, Crary SE. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder. Journal of Pediatric Hematology/Oncology 2018;40:e305-8. [DOI: 10.1097/mph.0000000000000981] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Hauck F, Magerus-Chatinet A, Vicca S, Rensing-Ehl A, Roesen-Wolff A, Roesler J, Rieux-Laucat F. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation. Clin Immunol 2013;147:61-8. [PMID: 23524443 DOI: 10.1016/j.clim.2013.02.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
99 Hannibal L, Lysne V, Bjørke-Monsen AL, Behringer S, Grünert SC, Spiekerkoetter U, Jacobsen DW, Blom HJ. Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency. Front Mol Biosci 2016;3:27. [PMID: 27446930 DOI: 10.3389/fmolb.2016.00027] [Cited by in Crossref: 113] [Cited by in F6Publishing: 94] [Article Influence: 18.8] [Reference Citation Analysis]
100 Kucuk ZY, Charbonnier LM, McMasters RL, Chatila T, Bleesing JJ. CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder. J Allergy Clin Immunol 2017;140:862-864.e4. [PMID: 28366794 DOI: 10.1016/j.jaci.2017.02.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
101 Simesen de Bielke MG, Yancoski J, Rocco C, Pérez LE, Cantisano C, Pérez N, Oleastro M, Danielian S. A Missense Mutation in the Extracellular Domain of Fas: The Most Common Change in Argentinean Patients with Autoimmune Lymphoproliferative Syndrome Represents a Founder Effect. J Clin Immunol 2012;32:1197-203. [DOI: 10.1007/s10875-012-9731-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
102 Li P, Huang P, Yang Y, Hao M, Peng H, Li F. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS). Clin Rev Allergy Immunol 2016;50:55-63. [PMID: 25663566 DOI: 10.1007/s12016-015-8466-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
103 Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood 2016;127:17-28. [PMID: 26504182 DOI: 10.1182/blood-2015-07-657981] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 14.3] [Reference Citation Analysis]
104 Fatone MC, Pavone F, Lauletta G, Russi S. Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia. Autoimmunity 2018;51:166-74. [PMID: 29845877 DOI: 10.1080/08916934.2018.1477132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
105 Langan RC, Gill F, Raiji MT, Mullinax JE, Pittaluga S, Pandalai P, Davis J, Perkins K, Avital I, Rudloff U. Autoimmune pancreatitis in the autoimmune lymphoproliferative syndrome (ALPS): a sheep in wolves' clothing? Pancreas 2013;42:363-6. [PMID: 23407489 DOI: 10.1097/MPA.0b013e3182648778] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
106 Pachlopnik Schmid J, Güngör T, Seger R. Modern management of primary T-cell immunodeficiencies. Pediatr Allergy Immunol 2014;25:300-13. [DOI: 10.1111/pai.12179] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
107 Alsultan A, Basher E, Alqanatish J, Mohammed R, Alfadhel M. Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis. Pediatr Blood Cancer 2018;65:e26912. [DOI: 10.1002/pbc.26912] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
108 Abraham RS. How to evaluate for immunodeficiency in patients with autoimmune cytopenias: laboratory evaluation for the diagnosis of inborn errors of immunity associated with immune dysregulation. Hematology Am Soc Hematol Educ Program 2020;2020:661-72. [PMID: 33275711 DOI: 10.1182/hematology.2020000173] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Jamee M, Hosseinzadeh S, Sharifinejad N, Zaki-Dizaji M, Matloubi M, Hasani M, Baris S, Alsabbagh M, Lo B, Azizi G. Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review. Clin Exp Immunol 2021;205:28-43. [PMID: 33788257 DOI: 10.1111/cei.13600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
110 El-sayed ZA, El-owaidy RH, Mohamed NL, Shehata BA. Alpha beta double negative T cells in children with systemic lupus erythematosus: The relation to disease activity and characteristics. Modern Rheumatology 2018;28:654-60. [DOI: 10.1080/14397595.2017.1377146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
111 Wang W, Zhou Y, Zhong L, Wang L, Tang X, Ma M, Li J, Song H. RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children. Pediatr Rheumatol Online J 2019;17:55. [PMID: 31412876 DOI: 10.1186/s12969-019-0346-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
112 Rao VK, Oliveira JB. How I treat autoimmune lymphoproliferative syndrome. Blood 2011;118:5741-51. [PMID: 21885601 DOI: 10.1182/blood-2011-07-325217] [Cited by in Crossref: 108] [Cited by in F6Publishing: 74] [Article Influence: 9.8] [Reference Citation Analysis]
113 Revel-Vilk S, Fischer U, Keller B, Nabhani S, Gámez-Díaz L, Rensing-Ehl A, Gombert M, Hönscheid A, Saleh H, Shaag A, Borkhardt A, Grimbacher B, Warnatz K, Elpeleg O, Stepensky P. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. Clin Immunol 2015;159:84-92. [PMID: 25931386 DOI: 10.1016/j.clim.2015.04.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 9.3] [Reference Citation Analysis]
114 Rensing-Ehl A, Janda A, Lorenz MR, Gladstone BP, Fuchs I, Abinun M, Albert M, Butler K, Cant A, Cseh AM, Ebinger M, Goldacker S, Hambleton S, Hebart H, Houet L, Kentouche K, Kühnle I, Lehmberg K, Mejstrikova E, Niemeyer C, Minkov M, Neth O, Dückers G, Owens S, Rösler J, Schilling FH, Schuster V, Seidel MG, Smisek P, Sukova M, Svec P, Wiesel T, Gathmann B, Schwarz K, Vach W, Ehl S, Speckmann C. Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia. Haematologica 2013;98:1948-55. [PMID: 23850805 DOI: 10.3324/haematol.2012.081901] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
115 Ruiz-García R, Mora S, Lozano-Sánchez G, Martínez-Lostao L, Paz-Artal E, Ruiz-Contreras J, Anel A, González-Granado LI, Moreno-Pérez D, Allende LM. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation. Pediatr Res 2015;78:603-8. [PMID: 26334989 DOI: 10.1038/pr.2015.170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
116 Notarangelo LD, Uzel G, Rao VK. Primary immunodeficiencies: novel genes and unusual presentations. Hematology Am Soc Hematol Educ Program 2019;2019:443-8. [PMID: 31808899 DOI: 10.1182/hematology.2019000051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
117 Gru AA, O’malley DP. Autoimmune and medication-induced lymphadenopathies. Seminars in Diagnostic Pathology 2018;35:34-43. [DOI: 10.1053/j.semdp.2017.11.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
118 Miano M, Calvillo M, Palmisani E, Fioredda F, Micalizzi C, Svahn J, Banov L, Russo G, Lanza T, Dufour C. Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children. Br J Haematol 2014;167:571-4. [DOI: 10.1111/bjh.13010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
119 Hedrich CM, Rauen T, Crispin JC, Koga T, Ioannidis C, Zajdel M, Kyttaris VC, Tsokos GC. cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease. J Biol Chem 2013;288:31880-7. [PMID: 24047902 DOI: 10.1074/jbc.M113.508655] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
120 Baker TS, Gambino KJ, Schriefer L, Lim JY, Steinberg KM, Fajgenbaum DC, Martín García-Sancho A, Byun M. A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease. Blood Adv 2018;2:2959-63. [PMID: 30404775 DOI: 10.1182/bloodadvances.2018023911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
121 Tessarin G, Mazza C, Baronio M, Gazzurelli L, Rossi S, Moratto D, Badolato R, Rensing-Ehl A, Ehl S, Warnatz K, Rosanelli C, Morello E, Plebani A, Lougaris V. Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS). Clin Immunol 2021;228:108757. [PMID: 33992756 DOI: 10.1016/j.clim.2021.108757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Rais A, Mekki N, Fedhila F, Alosaimi MF, Ben Khaled M, Zameli A, Agrebi N, Sellami MK, Geha R, Ben-Mustapha I, Barbouche MR. Case Report: FOXP3 Mutation in a Patient Presenting With ALPS. Front Immunol 2021;12:692107. [PMID: 34531853 DOI: 10.3389/fimmu.2021.692107] [Reference Citation Analysis]
123 Rensing-ehl A, Völkl S, Speckmann C, Lorenz MR, Ritter J, Janda A, Abinun M, Pircher H, Bengsch B, Thimme R, Fuchs I, Ammann S, Allgäuer A, Kentouche K, Cant A, Hambleton S, Bettoni da Cunha C, Huetker S, Kühnle I, Pekrun A, Seidel MG, Hummel M, Mackensen A, Schwarz K, Ehl S. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency. Blood 2014;124:851-60. [DOI: 10.1182/blood-2014-03-564286] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
124 Grimes AB, Kim TO, Kirk SE, Flanagan J, Lambert MP, Grace RF, Despotovic JM. Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic immune dysregulation. Eur J Haematol 2021;106:783-7. [PMID: 33570766 DOI: 10.1111/ejh.13600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Ducassou S, Gourdonneau A, Fernandes H, Leverger G, Pasquet M, Fouyssac F, Bayart S, Bertrand Y, Michel G, Jeziorski E, Thomas C, Abouchallah W, Viard F, Guitton C, Cheikh N, Pellier I, Carausu L, Droz C, Leblanc T, Aladjidi N; Centre de Référence National des Cytopénies Auto-immunes de l’Enfant (CEREVANCE). Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years. Br J Haematol 2020;189:931-42. [PMID: 32130726 DOI: 10.1111/bjh.16448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
126 Ashoka A, Bilal J. Generalized Lymphadenopathy with Cytopenias. Am J Med 2021;134:e490-1. [PMID: 34010601 DOI: 10.1016/j.amjmed.2021.03.048] [Reference Citation Analysis]
127 Audia S, Grienay N, Mounier M, Michel M, Bonnotte B. Evans' Syndrome: From Diagnosis to Treatment. J Clin Med 2020;9:E3851. [PMID: 33260979 DOI: 10.3390/jcm9123851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
128 Aberdein D, Munday J, Dittmer K, Heathcott R, Lyons L. Frequency of a FAS ligand gene variant associated with inherited feline autoimmune lymphoproliferative syndrome in British shorthair cats in New Zealand. New Zealand Veterinary Journal 2017;65:327-31. [DOI: 10.1080/00480169.2017.1367731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
129 Fortner KA, Bond JP, Austin JW, Boss JM, Budd RC. The molecular signature of murine T cell homeostatic proliferation reveals both inflammatory and immune inhibition patterns. J Autoimmun 2017;82:47-61. [PMID: 28551033 DOI: 10.1016/j.jaut.2017.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
130 López-Nevado M, González-Granado LI, Ruiz-García R, Pleguezuelo D, Cabrera-Marante O, Salmón N, Blanco-Lobo P, Domínguez-Pinilla N, Rodríguez-Pena R, Sebastián E, Cruz-Rojo J, Olbrich P, Ruiz-Contreras J, Paz-Artal E, Neth O, Allende LM. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. Front Immunol 2021;12:671755. [PMID: 34447369 DOI: 10.3389/fimmu.2021.671755] [Reference Citation Analysis]
131 Forbes LR, Eckstein OS, Gulati N, Peckham-Gregory EC, Ozuah NW, Lubega J, El-Mallawany NK, Agrusa J, Poli MC, Vogel TP, Chaimowitz NS, Rider NL, Mace EM, Orange JS, Caldwell JW, Aldave-Becerra JC, Jolles S, Saettini F, Chong HJ, Stray-Pedersen A, Heslop HE, Kamdar KY, Rouce RH, Muzny DM, Jhangiani SN, Gibbs RA, Coban-Akdemir ZH, Lupski JR, McClain KL, Allen CE, Chinn IK. Genetic errors of immunity distinguish pediatric non-malignant lymphoproliferative disorders. J Allergy Clin Immunol 2021:S0091-6749(21)01135-0. [PMID: 34329649 DOI: 10.1016/j.jaci.2021.07.015] [Reference Citation Analysis]
132 Lev A, Simon AJ, Amariglio N, Rechavi G, Somech R. Thymic functions and gene expression profile distinct double-negative cells from single positive cells in the autoimmune lymphoproliferative syndrome. Autoimmunity Reviews 2012;11:723-30. [DOI: 10.1016/j.autrev.2012.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
133 George LA, Teachey DT. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children. Pediatr Drugs 2016;18:261-72. [DOI: 10.1007/s40272-016-0175-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
134 Ben-Mustapha I, Agrebi N, Barbouche MR. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients. J Leukoc Biol 2018;103:501-8. [PMID: 29345341 DOI: 10.1002/JLB.5MR0817-332R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
135 Mao H, Yang W, Latour S, Yang J, Winter S, Zheng J, Ni K, Lv M, Liu C, Huang H, Chan K, Pui-wah Lee P, Tu W, Fischer A, Lau Y. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease. Journal of Allergy and Clinical Immunology 2018;142:595-604.e16. [DOI: 10.1016/j.jaci.2017.10.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
136 Cagdas D, Halaçlı SO, Tan Ç, Lo B, Çetinkaya PG, Esenboğa S, Karaatmaca B, Matthews H, Balcı-Hayta B, Arıkoğlu T, Ezgü F, Aladağ E, Saltık-Temizel İN, Demir H, Kuşkonmaz B, Okur V, Gümrük F, Göker H, Çetinkaya D, Boztuğ K, Lenardo M, Sanal Ö, Tezcan İ. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects. J Clin Immunol 2019;39:726-38. [PMID: 31432443 DOI: 10.1007/s10875-019-00677-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
137 Allen CE. ALPS DNT cells: active senior living with mTOR. Blood 2016;128:152-152. [DOI: 10.1182/blood-2016-05-713032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
138 Plander M, Kalman B. Rare autoimmune disorders with Mendelian inheritance. Autoimmunity 2016;49:285-97. [PMID: 27207228 DOI: 10.1080/08916934.2016.1183658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
139 Staels F, Collignon T, Betrains A, Gerbaux M, Willemsen M, Humblet-Baron S, Liston A, Vanderschueren S, Schrijvers R. Monogenic Adult-Onset Inborn Errors of Immunity. Front Immunol 2021;12:753978. [PMID: 34867986 DOI: 10.3389/fimmu.2021.753978] [Reference Citation Analysis]
140 Ben-Chetrit E, Bnaya A, Vernea F, Somech R, Ashkenazi YJ. Sometimes double negative is positive. Arthritis Care Res (Hoboken) 2013;65:161-8. [PMID: 22933320 DOI: 10.1002/acr.21832] [Reference Citation Analysis]
141 Sogkas G, Atschekzei F, Adriawan IR, Dubrowinskaja N, Witte T, Schmidt RE. Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. Cell Mol Immunol 2021;18:1122-40. [PMID: 33795850 DOI: 10.1038/s41423-020-00626-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Shaikh F, Ngan B, Alexander S, Grant R. Progressive transformation of germinal centers in children and adolescents: An intriguing cause of lymphadenopathy. Pediatr Blood Cancer 2013;60:26-30. [DOI: 10.1002/pbc.24234] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
143 Locatelli F, Algeri M, Merli P, Strocchio L. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia. Expert Review of Hematology 2018;11:129-43. [DOI: 10.1080/17474086.2018.1421937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
144 Neven B, Magerus-chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, Lanzarotti N, Stolzenberg M, Bader-meunier B, Aladjidi N, Chantrain C, Bertrand Y, Jeziorski E, Leverger G, Michel G, Suarez F, Oksenhendler E, Hermine O, Blanche S, Picard C, Fischer A, Rieux-laucat F. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 2011;118:4798-807. [DOI: 10.1182/blood-2011-04-347641] [Cited by in Crossref: 103] [Cited by in F6Publishing: 79] [Article Influence: 9.4] [Reference Citation Analysis]
145 Cayrol J, Garrido Colino C. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports. Journal of Pediatric Hematology/Oncology 2017;39:e187-90. [DOI: 10.1097/mph.0000000000000785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
146 Riller Q, Rieux-Laucat F. RASopathies: from germline mutations to somatic and multigenic diseases. Biomed J 2021:S2319-4170(21)00070-6. [PMID: 34175492 DOI: 10.1016/j.bj.2021.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D. Evans syndrome: clinical perspectives, biological insights and treatment modalities. J Blood Med 2018;9:171-84. [PMID: 30349415 DOI: 10.2147/JBM.S176144] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
148 Kurma K, Boizard-Moracchini A, Galli G, Jean M, Vacher P, Blanco P, Legembre P. Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target? Biochim Biophys Acta Rev Cancer 2021;1876:188596. [PMID: 34324950 DOI: 10.1016/j.bbcan.2021.188596] [Reference Citation Analysis]
149 Tripodi SI, Mazza C, Moratto D, Ramenghi U, Caorsi R, Gattorno M, Badolato R. Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation. Immunology Letters 2016;177:22-4. [DOI: 10.1016/j.imlet.2016.07.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
150 Suárez-Fueyo A, Bradley SJ, Klatzmann D, Tsokos GC. T cells and autoimmune kidney disease. Nat Rev Nephrol 2017;13:329-43. [PMID: 28287110 DOI: 10.1038/nrneph.2017.34] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
151 Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, Hussey AA, Evbuomwan MO, Priel DA, Kuhns DB, Park CL, Fleisher TA, Uzel G, Oliveira JB. Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans. Blood 2013;121:3117-25. [PMID: 23430113 DOI: 10.1182/blood-2012-12-469544] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 10.6] [Reference Citation Analysis]
152 Rodríguez-Rodríguez N, Flores-Mendoza G, Apostolidis SA, Rosetti F, Tsokos GC, Crispín JC. TCR-α/β CD4- CD8- double negative T cells arise from CD8+ T cells. J Leukoc Biol 2020;108:851-7. [PMID: 32052478 DOI: 10.1002/JLB.1AB0120-548R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
153 Klemann C, Esquivel M, Magerus-Chatinet A, Lorenz MR, Fuchs I, Neveux N, Castelle M, Rohr J, da Cunha CB, Ebinger M, Kobbe R, Kremens B, Kollert F, Gambineri E, Lehmberg K, Seidel MG, Siepermann K, Voelker T, Schuster V, Goldacker S, Schwarz K, Speckmann C, Picard C, Fischer A, Rieux-Laucat F, Ehl S, Rensing-Ehl A, Neven B. Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome. Haematologica 2017;102:e52-6. [PMID: 27789675 DOI: 10.3324/haematol.2016.153411] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
154 Miano M, Ramenghi U, Russo G, Rubert L, Barone A, Tucci F, Farruggia P, Petrone A, Mondino A, Lo Valvo L, Crescenzio N, Bellia F, Olivieri I, Palmisani E, Caviglia I, Dufour C, Fioredda F. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology. Br J Haematol 2016;175:490-5. [PMID: 27447678 DOI: 10.1111/bjh.14261] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
155 Barrett D, Brown VI, Grupp SA, Teachey DT. Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies. Pediatr Drugs 2012;14:299-316. [DOI: 10.1007/bf03262236] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
156 Liapis K, Tsagarakis NJ, Panitsas F, Taparkou A, Liapis I, Roubakis C, Tsokanas D, Vasileiou P, Grigoriou E, Kakiopoulos G, Psarra K, Farmaki E, Paterakis G. Causes of double-negative T-cell lymphocytosis in children and adults. J Clin Pathol 2020;73:431-8. [PMID: 31810993 DOI: 10.1136/jclinpath-2019-206255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
157 Raje N, Dinakar C. Overview of Immunodeficiency Disorders. Immunol Allergy Clin North Am 2015;35:599-623. [PMID: 26454309 DOI: 10.1016/j.iac.2015.07.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
158 Minemura H, Ikeda K, Tanino Y, Hashimoto Y, Nikaido T, Fukuhara A, Yokouchi H, Sato S, Tanino M, Oka T, Hebisawa A, Suzuki H, Ogawa K, Takeishi Y, Munakata M. Multicentric Castleman's disease with impaired lymphocytic apoptosis. Allergol Int 2015;64:112-4. [PMID: 25572569 DOI: 10.1016/j.alit.2014.08.009] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
159 Farmer JR, Sokol CL, Bonilla FA, Murali MR, Kradin RL, Astor TL, Walter JE. Bilateral lung transplantation in a patient with humoral immune deficiency: a case report with review of the literature. Case Reports Immunol 2014;2014:910215. [PMID: 25379312 DOI: 10.1155/2014/910215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
160 Clemente N, Boggio E, Gigliotti CL, Orilieri E, Cappellano G, Toth E, Valletti PA, Santoro C, Quinti I, Pignata C, Notarangelo LD, Dianzani C, Dianzani I, Ramenghi U, Dianzani U, Chiocchetti A. A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation. Genes Immun 2015;16:151-61. [PMID: 25569260 DOI: 10.1038/gene.2014.74] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
161 Moraitis AG, Freeman LA, Shamburek RD, Wesley R, Wilson W, Grant CM, Price S, Demosky S, Thacker SG, Zarzour A, Hornung RL, Pucino F, Csako G, Yarboro C, McInnes IB, Kuroiwa T, Boumpas D, Rao VK, Illei GG, Remaley AT. Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency. J Clin Lipidol 2015;9:81-90. [PMID: 25670364 DOI: 10.1016/j.jacl.2014.09.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
162 Waterfield M, Anderson MS. Clues to immune tolerance: the monogenic autoimmune syndromes. Ann N Y Acad Sci 2010;1214:138-55. [PMID: 20969580 DOI: 10.1111/j.1749-6632.2010.05818.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
163 Rieux-Laucat F, Magerus-Chatinet A. Autoimmune lymphoproliferative syndrome: a multifactorial disorder. Haematologica 2010;95:1805-7. [PMID: 21037326 DOI: 10.3324/haematol.2010.030395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
164 van der Werff ten Bosch J, van den Akker M. Genetic predisposition and hematopoietic malignancies in children: Primary immunodeficiency. European Journal of Medical Genetics 2016;59:647-53. [DOI: 10.1016/j.ejmg.2016.03.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
165 Singh A, Jindal AK, Joshi V, Anjani G, Rawat A. An updated review on phenocopies of primary immunodeficiency diseases. Genes Dis 2020;7:12-25. [PMID: 32181272 DOI: 10.1016/j.gendis.2019.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
166 Tamaki K, Morishima S, Nakachi S, Kitamura S, Uchibori S, Tomori S, Hanashiro T, Shimabukuro N, Tedokon I, Morichika K, Nishi Y, Tomoyose T, Karube K, Fukushima T, Masuzaki H. An atypical case of late-onset systemic lupus erythematosus with systemic lymphadenopathy and severe autoimmune thrombocytopenia/neutropenia mimicking malignant lymphoma. Int J Hematol 2017;105:526-31. [PMID: 27848183 DOI: 10.1007/s12185-016-2126-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
167 Boggio E, Clemente N, Mondino A, Cappellano G, Orilieri E, Gigliotti CL, Toth E, Ramenghi U, Dianzani U, Chiocchetti A. IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes. Blood 2014;123:1178-86. [PMID: 24363402 DOI: 10.1182/blood-2013-07-518167] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
168 Knight V. The utility of flow cytometry for the diagnosis of primary immunodeficiencies. Int J Lab Hematol 2019;41:63-72. [DOI: 10.1111/ijlh.13010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
169 Roberts C, Ayers L, Bateman E, Sadler R, Magerus-chatinet A, Rieux-laucat F, Misbah S, Ferry B. Investigation of common variable immunodeficiency patients and healthy individuals using autoimmune lymphoproliferative syndrome biomarkers. Human Immunology 2013;74:1531-5. [DOI: 10.1016/j.humimm.2013.08.266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
170 Tommasini A, Valencic E, Piscianz E, Rabusin M. Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer 2012;58:310-310. [DOI: 10.1002/pbc.23205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
171 Stremenova Spegarova J, Lawless D, Mohamad SMB, Engelhardt KR, Doody G, Shrimpton J, Rensing-Ehl A, Ehl S, Rieux-Laucat F, Cargo C, Griffin H, Mikulasova A, Acres M, Morgan NV, Poulter JA, Sheridan EG, Chetcuti P, O'Riordan S, Anwar R, Carter CR, Przyborski S, Windebank K, Cant AJ, Lako M, Bacon CM, Savic S, Hambleton S. Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. Blood 2020;136:1055-66. [PMID: 32518946 DOI: 10.1182/blood.2020005844] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 18.0] [Reference Citation Analysis]
172 Perazzio SF, Palmeira P, Moraes-Vasconcelos D, Rangel-Santos A, de Oliveira JB, Andrade LEC, Carneiro-Sampaio M. A Critical Review on the Standardization and Quality Assessment of Nonfunctional Laboratory Tests Frequently Used to Identify Inborn Errors of Immunity. Front Immunol 2021;12:721289. [PMID: 34858394 DOI: 10.3389/fimmu.2021.721289] [Reference Citation Analysis]
173 Delmonte OM, Fleisher TA. Flow cytometry: Surface markers and beyond. J Allergy Clin Immunol 2019;143:528-37. [PMID: 30170120 DOI: 10.1016/j.jaci.2018.08.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
174 Chandrakasan S, Chandra S, Davila Saldana BJ, Torgerson TR, Buchbinder D. Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case‐based review. Pediatr Blood Cancer 2019;66:e27619. [DOI: 10.1002/pbc.27619] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
175 Bussel JB, Cooper N. Immune thrombocytopenia: a need for assisted suicide. Br J Haematol 2017;176:154-154. [DOI: 10.1111/bjh.14435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
176 Nabhani S, Hönscheid A, Oommen PT, Fleckenstein B, Schaper J, Kuhlen M, Laws H, Borkhardt A, Fischer U. A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome. Clinical Immunology 2014;155:231-7. [DOI: 10.1016/j.clim.2014.10.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
177 Miano M, Madeo A, Cappelli E, Lanza F, Lanza T, Stroppiano M, Terranova P, Venè R, Bleesing JJH, Di Rocco M. Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease. J Allergy Clin Immunol Pract 2020;8:3535-42. [PMID: 32702516 DOI: 10.1016/j.jaip.2020.06.065] [Reference Citation Analysis]
178 Price V. Auto-immune lymphoproliferative disorder and other secondary immune thrombocytopenias in childhood. Pediatr Blood Cancer 2013;60:S12-4. [DOI: 10.1002/pbc.24343] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
179 Fleisher TA, Madkaikar M, Rosenzweig SD. Application of Flow Cytometry in the Evaluation of Primary Immunodeficiencies. Indian J Pediatr 2016;83:444-9. [PMID: 26865168 DOI: 10.1007/s12098-015-2011-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
180 Kram DE, Santarelli MD, Russell TB, Pearsall KB, Saldaña BD. STX11‐deficient familial hemophagocytic lymphohistiocytosis type 4 is associated with self‐resolving flares and a milder clinical course. Pediatr Blood Cancer 2019;66. [DOI: 10.1002/pbc.27890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Szczawińska-Popłonyk A, Grześk E, Schwartzmann E, Materna-Kiryluk A, Małdyk J. Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge. Front Pediatr 2021;9:798959. [PMID: 35036396 DOI: 10.3389/fped.2021.798959] [Reference Citation Analysis]
182 Meynier S, Rieux-Laucat F. FAS and RAS related Apoptosis defects: From autoimmunity to leukemia. Immunol Rev 2019;287:50-61. [PMID: 30565243 DOI: 10.1111/imr.12720] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
183 Sharifinejad N, Azizi G, Behniafard N, Zaki-Dizaji M, Jamee M, Yazdani R, Abolhassani H, Aghamohammadi A. Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature. Immunol Invest 2020;:1-12. [PMID: 33047643 DOI: 10.1080/08820139.2020.1829638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
184 Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am 2013;60:1489-511. [PMID: 24237984 DOI: 10.1016/j.pcl.2013.08.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
185 Carrasquillo JA, Chen CC, Price S, Whatley M, Avila NA, Pittaluga S, Jaffe ES, Rao VK. 18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome. Clin Nucl Med 2019;44:949-55. [PMID: 31689275 DOI: 10.1097/RLU.0000000000002816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Takagi M, Hoshino A, Yoshida K, Ueno H, Imai K, Piao J, Kanegane H, Yamashita M, Okano T, Muramatsu H, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Hayashi Y, Kojima S, Morio T. Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferation. Pediatr Blood Cancer 2018;65:e26831. [DOI: 10.1002/pbc.26831] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
187 Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, Rao VK. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood 2015;125:2753-8. [PMID: 25691160 DOI: 10.1182/blood-2014-11-567917] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
188 Galicier L, Boutboul D, Oksenhendler É, Fieschi C, Meignin V. Histiocytose sinusale de Rosai–Dorfman. La Presse Médicale 2017;46:107-16. [DOI: 10.1016/j.lpm.2016.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
189 van de Ven AAJM, Seidl M, Drendel V, Schmitt-Graeff A, Voll RE, Rensing-Ehl A, Speckmann C, Ehl S, Warnatz K, Kollert F. IgG4-related disease in autoimmune lymphoproliferative syndrome. Clin Immunol 2017;180:97-9. [PMID: 28478106 DOI: 10.1016/j.clim.2017.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
190 Völkl S, Rensing-Ehl A, Allgäuer A, Schreiner E, Lorenz MR, Rohr J, Klemann C, Fuchs I, Schuster V, von Bueren AO, Naumann-Bartsch N, Gambineri E, Siepermann K, Kobbe R, Nathrath M, Arkwright PD, Miano M, Stachel KD, Metzler M, Schwarz K, Kremer AN, Speckmann C, Ehl S, Mackensen A. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome. Blood 2016;128:227-38. [PMID: 27099149 DOI: 10.1182/blood-2015-11-685024] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
191 Gormezano NW, Kern D, Pereira OL, Esteves GC, Sallum AM, Aikawa NE, Pereira RM, Silva CA, Bonfá E. Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients. Lupus 2017;26:426-30. [PMID: 27821514 DOI: 10.1177/0961203316676379] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
192 Comrie WA, Lenardo MJ. Molecular Classification of Primary Immunodeficiencies of T Lymphocytes. Adv Immunol 2018;138:99-193. [PMID: 29731008 DOI: 10.1016/bs.ai.2018.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
193 Fischer A. Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies. Trends in Molecular Medicine 2015;21:408-16. [DOI: 10.1016/j.molmed.2015.04.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
194 Chinn IK, Chan AY, Chen K, Chou J, Dorsey MJ, Hajjar J, Jongco AM 3rd, Keller MD, Kobrynski LJ, Kumanovics A, Lawrence MG, Leiding JW, Lugar PL, Orange JS, Patel K, Platt CD, Puck JM, Raje N, Romberg N, Slack MA, Sullivan KE, Tarrant TK, Torgerson TR, Walter JE. Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2020;145:46-69. [PMID: 31568798 DOI: 10.1016/j.jaci.2019.09.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
195 Magerus A, Bercher-Brayer C, Rieux-Laucat F. The genetic landscape of the FAS pathway deficiencies. Biomed J 2021:S2319-4170(21)00071-8. [PMID: 34171534 DOI: 10.1016/j.bj.2021.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Gangadharan H, Singh A, Singh K, Rahman K, Aggarwal A. A Rare Cause of Double Negative αβ T Cell Lymphocytosis. Indian J Hematol Blood Transfus 2021;37:511-3. [PMID: 34267479 DOI: 10.1007/s12288-020-01381-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Farmer JR, DeLelys M. Flow Cytometry as a Diagnostic Tool in Primary and Secondary Immune Deficiencies. Clin Lab Med 2019;39:591-607. [PMID: 31668272 DOI: 10.1016/j.cll.2019.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Takagi M, Shinoda K, Piao J, Mitsuiki N, Takagi M, Matsuda K, Muramatsu H, Doisaki S, Nagasawa M, Morio T, Kasahara Y, Koike K, Kojima S, Takao A, Mizutani S. Autoimmune lymphoproliferative syndrome–like disease with somatic KRAS mutation. Blood 2011;117:2887-90. [DOI: 10.1182/blood-2010-08-301515] [Cited by in Crossref: 99] [Cited by in F6Publishing: 83] [Article Influence: 9.0] [Reference Citation Analysis]
199 Oras A, Quirant-Sanchez B, Popadic D, Thunberg S, Winqvist O, Heck S, Cwikowski M, Riemann D, Seliger B, Martinez Caceres E, Uibo R, Giese T. Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across Europe. Clin Exp Immunol 2020;202:363-78. [PMID: 32654132 DOI: 10.1111/cei.13491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
200 Crane GM, Liu YC, Chadburn A. Spleen: Development, anatomy and reactive lymphoid proliferations. Semin Diagn Pathol 2021;38:112-24. [PMID: 32591155 DOI: 10.1053/j.semdp.2020.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
201 Lou W, Zhang X, Hu XY, Hu AR. MicroRNA-219-5p Inhibits Morphine-Induced Apoptosis by Targeting Key Cell Cycle Regulator WEE1. Med Sci Monit 2016;22:1872-9. [PMID: 27253431 DOI: 10.12659/msm.895439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
202 Seedhom MO, Mathurin KS, Kim SK, Welsh RM. Increased protection from vaccinia virus infection in mice genetically prone to lymphoproliferative disorders. J Virol 2012;86:6010-22. [PMID: 22438562 DOI: 10.1128/JVI.07176-11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
203 Cheng MH, Anderson MS. Monogenic autoimmunity. Annu Rev Immunol. 2012;30:393-427. [PMID: 22224765 DOI: 10.1146/annurev-immunol-020711-074953] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
204 Mainardi C, Pizzi M, Marzollo A, Carraro E, Boaro MP, Mussolin L, Massano D, Tazzoli S, Onofrillo D, Cesaro S, Farruggia P, Putti MC, Alaggio R, Biffi A, d'Amore ESG, Pillon M. Pediatric IgG4-related lymphadenopathy: A rare condition associated with autoimmunity and lymphoproliferative disorders. Pediatr Allergy Immunol 2020;31:332-6. [PMID: 31770465 DOI: 10.1111/pai.13182] [Reference Citation Analysis]
205 Tüfekçi Ö, Ören H, Demir Yenigürbüz F, Gözmen S, Karapınar TH, İrken G. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features. Turk J Haematol 2015;32:175-9. [PMID: 26316488 DOI: 10.4274/tjh.2014.0034] [Reference Citation Analysis]
206 Fleisher TA, Oliveira JB. Monogenic defects in lymphocyte apoptosis. Curr Opin Allergy Clin Immunol 2012;12:609-15. [PMID: 22918222 DOI: 10.1097/ACI.0b013e3283588da0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
207 Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood 2014;123:1989-99. [PMID: 24398331 DOI: 10.1182/blood-2013-10-535393] [Cited by in Crossref: 133] [Cited by in F6Publishing: 104] [Article Influence: 16.6] [Reference Citation Analysis]
208 Casamayor-Polo L, López-Nevado M, Paz-Artal E, Anel A, Rieux-Laucat F, Allende LM. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS). Crit Rev Clin Lab Sci 2021;58:253-74. [PMID: 33356695 DOI: 10.1080/10408363.2020.1855623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
209 Wang E, Papavassiliou P, Wei Q, Wickham MQ, Cichon L, Proia AD. An Epstein-Barr virus-positive diffuse large B-cell lymphoma presenting as multi-organ failure: a catastrophic lymphomatosis with fulminant visceral organ dissemination resulting in a precipitous death in a 59-year-old female with no identifiable etiology for immunodeficiency. Pathol Res Pract 2014;210:62-6. [PMID: 24120731 DOI: 10.1016/j.prp.2013.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
210 Yokoyama S, Perera PY, Terawaki S, Watanabe N, Kaminuma O, Waldmann TA, Hiroi T, Perera LP. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS). J Clin Immunol 2015;35:661-7. [PMID: 26453583 DOI: 10.1007/s10875-015-0203-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
211 Hutchison RE, Schexneider KI. Leukocytic Disorders. Henry's Clinical Diagnosis and Management by Laboratory Methods. Elsevier; 2011. pp. 601-55. [DOI: 10.1016/b978-1-4377-0974-2.00033-6] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
212 Rieux-Laucat F, Magérus-Chatinet A, Neven B. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions. J Clin Immunol 2018;38:558-68. [PMID: 29911256 DOI: 10.1007/s10875-018-0523-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
213 López-Nevado M, Docampo-Cordeiro J, Ramos JT, Rodríguez-Pena R, Gil-López C, Sánchez-Ramón S, Gil-Herrera J, Díaz-Madroñero MJ, Delgado-Martín MA, Morales-Pérez P, Paz-Artal E, Magerus A, Rieux-Laucat F, Allende LM. Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome. Front Immunol 2021;12:656356. [PMID: 33995372 DOI: 10.3389/fimmu.2021.656356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
214 Gaefke CL, Metts J, Imanirad D, Nieves D, Terranova P, Dell'Orso G, Gambineri E, Miano M, Lockey RF, Walter JE, Westermann-Clark E. Case Report: A Novel Pathogenic Missense Mutation in FAS: A Multi-Generational Case Series of Autoimmune Lymphoproliferative Syndrome. Front Pediatr 2021;9:624116. [PMID: 33816397 DOI: 10.3389/fped.2021.624116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Aladjidi N, Fernandes H, Leblanc T, Vareliette A, Rieux-Laucat F, Bertrand Y, Chambost H, Pasquet M, Mazingue F, Guitton C, Pellier I, Roqueplan-Bellmann F, Armari-Alla C, Thomas C, Marie-Cardine A, Lejars O, Fouyssac F, Bayart S, Lutz P, Piguet C, Jeziorski E, Rohrlich P, Lemoine P, Bodet D, Paillard C, Couillault G, Millot F, Fischer A, Pérel Y, Leverger G. Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort. Front Pediatr 2015;3:79. [PMID: 26484337 DOI: 10.3389/fped.2015.00079] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
216 Garrido Colino C. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome]. An Pediatr (Barc) 2014;80:122.e1-7. [PMID: 24055319 DOI: 10.1016/j.anpedi.2013.06.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
217 Grossi A, Miano M, Lanciotti M, Fioredda F, Guardo D, Palmisani E, Terranova P, Santamaria G, Caroli F, Caorsi R, Volpi S, Gattorno M, Dufour C, Ceccherini I. Targeted NGS Yields Plentiful Ultra-Rare Variants in Inborn Errors of Immunity Patients. Genes (Basel) 2021;12:1299. [PMID: 34573280 DOI: 10.3390/genes12091299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Zheng L, Li J, Lenardo M. Restimulation-induced cell death: new medical and research perspectives. Immunol Rev 2017;277:44-60. [PMID: 28462523 DOI: 10.1111/imr.12535] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
219 Agrebi N, Ben-Mustapha I, Matoussi N, Dhouib N, Ben-Ali M, Mekki N, Ben-Ahmed M, Larguèche B, Ben Becher S, Béjaoui M, Barbouche MR. Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome. Clin Immunol 2017;183:17-23. [PMID: 28668589 DOI: 10.1016/j.clim.2017.06.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
220 Miano M, Scalzone M, Perri K, Palmisani E, Caviglia I, Micalizzi C, Svahn J, Calvillo M, Banov L, Terranova P, Lanza T, Dufour C, Fioredda F. Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience. Br J Haematol 2015;171:247-53. [PMID: 26058843 DOI: 10.1111/bjh.13533] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
221 Dantuluri KL, Connelly JA, Hummell DS, Khan YW, Dulek DE. Bartonella endocarditis mimics the clinical and immunologic findings of autoimmune lymphoproliferative syndrome. Pediatr Blood Cancer 2020;67:e28325. [PMID: 32449580 DOI: 10.1002/pbc.28325] [Reference Citation Analysis]
222 Miano M, Rotulo GA, Palmisani E, Giaimo M, Fioredda F, Pierri F, Pezzulla A, Licciardello M, Terranova P, Lanza T, Cappelli E, Maggiore R, Calvillo M, Micalizzi C, Russo G, Dufour C. Sirolimus as a rescue therapy in children with immune thrombocytopenia refractory to mycophenolate mofetil. Am J Hematol 2018;93:E175-7. [DOI: 10.1002/ajh.25119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
223 Sève P, Broussolle C, Pavic M. [Primary immunodeficiencies presenting with autoimmune cytopenias in adults]. Rev Med Interne 2013;34:148-53. [PMID: 22703729 DOI: 10.1016/j.revmed.2012.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
224 Cistaro A, Pazè F, Durando S, Cogoni M, Faletti R, Vesco S, Vallero S, Quartuccio N, Treglia G, Ramenghi U. Autoimmune lymphoproliferative syndrome and non-Hodgkin lymphoma: what 18F-fluorodeoxyglucose positron emission tomography/computed tomography can do in the management of these patients? Suggestions from a case report. Rev Esp Med Nucl Imagen Mol 2014;33:99-102. [PMID: 23845452 DOI: 10.1016/j.remn.2013.05.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
225 Glerup M, Herlin T, Rittig S, Grønbæk K, Hokland M, Hasle H. Tubulointerstitial nephritis in a patient with probable autoimmune lymphoproliferative syndrome. J Pediatr Hematol Oncol 2013;35:e187-9. [PMID: 23588339 DOI: 10.1097/MPH.0b013e31828ac9fe] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
226 Saettini F, Herriot R, Prada E, Nizon M, Zama D, Marzollo A, Romaniouk I, Lougaris V, Cortesi M, Morreale A, Kosaki R, Cardinale F, Ricci S, Domínguez-Garrido E, Montin D, Vincent M, Milani D, Biondi A, Gervasini C, Badolato R. Prevalence of Immunological Defects in a Cohort of 97 Rubinstein-Taybi Syndrome Patients. J Clin Immunol 2020;40:851-60. [PMID: 32594341 DOI: 10.1007/s10875-020-00808-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
227 Shiota M, Yang X, Kubokawa M, Morishima T, Tanaka K, Mikami M, Yoshida K, Kikuchi M, Izawa K, Nishikomori R, Okuno Y, Wang X, Sakaguchi H, Muramatsu H, Kojima S, Miyano S, Ogawa S, Takagi M, Hata D, Kanegane H. Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases. J Clin Immunol 2015;35:454-8. [PMID: 25896945 DOI: 10.1007/s10875-015-0163-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
228 Aberdein D, Munday JS, Gandolfi B, Dittmer KE, Malik R, Garrick DJ, Lyons LA; 99 Lives Consortium. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats. Mamm Genome 2017;28:47-55. [DOI: 10.1007/s00335-016-9668-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
229 Lau CY, Mihalek AD, Wang J, Dodd LE, Perkins K, Price S, Webster S, Pittaluga S, Folio LR, Rao VK, Olivier KN. Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort. Ann Am Thorac Soc 2016;13:1279-88. [PMID: 27268092 DOI: 10.1513/AnnalsATS.201601-079OC] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
230 Kuehn HS, Caminha I, Niemela JE, Rao VK, Davis J, Fleisher TA, Oliveira JB. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome. J Immunol 2011;186:6035-43. [PMID: 21490157 DOI: 10.4049/jimmunol.1100021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
231 Chandramati J, Sidharthan N, Ponthenkandath S. Neonatal Autoimmune Lymphoproliferative Syndrome: A Case Report and A Brief Review. J Pediatr Hematol Oncol 2021;43:e227-9. [PMID: 32149866 DOI: 10.1097/MPH.0000000000001777] [Reference Citation Analysis]
232 Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr 2012;24:1-8. [PMID: 22157362 DOI: 10.1097/MOP.0b013e32834ea739] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
233 Boggio E, Gigliotti CL, Rossi D, Toffoletti E, Cappellano G, Clemente N, Puglisi S, Lunghi M, Cerri M, Vianelli N, Cantoni S, Tieghi A, Beggiato E, Gaidano G, Comi C, Chiocchetti A, Fanin R, Dianzani U, Zaja F. Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia. Br J Haematol 2017;176:258-67. [DOI: 10.1111/bjh.14248] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
234 Bowen RA, Dowdell KC, Dale JK, Drake SK, Fleisher TA, Hortin GL, Remaley AT, Nexo E, Rao VK. Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes. Clin Biochem 2012;45:490-2. [PMID: 22306884 DOI: 10.1016/j.clinbiochem.2012.01.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
235 Schipp C, Schlütermann D, Hönscheid A, Nabhani S, Höll J, Oommen PT, Ginzel S, Fleckenstein B, Stork B, Borkhardt A, Stepensky P, Fischer U. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency. Front Immunol 2018;9:2400. [PMID: 30386345 DOI: 10.3389/fimmu.2018.02400] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
236 Delitala M, Dianzani U, Lorenzi T, Melensi M. A mathematical model for immune and autoimmune response mediated by T -cells. Computers & Mathematics with Applications 2013;66:1010-23. [DOI: 10.1016/j.camwa.2013.06.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
237 Niss O, Sholl A, Bleesing JJ, Hildeman DA. IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol 2015;135:762-70. [PMID: 25174872 DOI: 10.1016/j.jaci.2014.07.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
238 Nomura A, Noto D, Murayama G, Chiba A, Miyake S. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice. Arthritis Res Ther 2019;21:303. [PMID: 31888754 DOI: 10.1186/s13075-019-2067-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
239 Forghieri F, Luppi M, Barozzi P, Riva G, Morselli M, Bigliardi S, Quadrelli C, Vallerini D, Maccaferri M, Coluccio V, Paolini A, Colaci E, Bonacorsi G, Maiorana A, Tagliazucchi S, Rumpianesi F, Mattioli F, Presutti L, Gelmini R, Cermelli C, Rossi G, Comoli P, Marasca R, Narni F, Potenza L. Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation. Br J Haematol 2016;172:561-72. [PMID: 26684692 DOI: 10.1111/bjh.13871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
240 Rieux-laucat F. What's up in the ALPS. Current Opinion in Immunology 2017;49:79-86. [DOI: 10.1016/j.coi.2017.10.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]